276 related articles for article (PubMed ID: 8642292)
1. Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?
Takahashi H; Nakagawa Y; Leggatt GR; Ishida Y; Saito T; Yokomuro K; Berzofsky JA
J Exp Med; 1996 Mar; 183(3):879-89. PubMed ID: 8642292
[TBL] [Abstract][Full Text] [Related]
2. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
[TBL] [Abstract][Full Text] [Related]
3. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein.
Takahashi H; Houghten R; Putney SD; Margulies DH; Moss B; Germain RN; Berzofsky JA
J Exp Med; 1989 Dec; 170(6):2023-35. PubMed ID: 2479705
[TBL] [Abstract][Full Text] [Related]
5. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
[TBL] [Abstract][Full Text] [Related]
6. Role of conserved regions of class I MHC molecules in the activation of CD8+ cytotoxic T lymphocytes by peptide and purified cell-free class I molecules.
Takeshita T; Kozlowski S; England RD; Brower R; Schneck J; Takahashi H; DeLisi C; Margulies DH; Berzofsky JA
Int Immunol; 1993 Sep; 5(9):1129-38. PubMed ID: 8241055
[TBL] [Abstract][Full Text] [Related]
7. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.
Takahashi H; Nakagawa Y; Yokomuro K; Berzofsky JA
Int Immunol; 1993 Aug; 5(8):849-57. PubMed ID: 8398980
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
Rich RF; Green WR
J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
Bergmann CC; Tong L; Cua RV; Sensintaffar JL; Stohlman SA
J Immunol; 1994 Jun; 152(12):5603-12. PubMed ID: 7515908
[TBL] [Abstract][Full Text] [Related]
10. An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself.
Takahashi H; Germain RN; Moss B; Berzofsky JA
J Exp Med; 1990 Feb; 171(2):571-6. PubMed ID: 1689366
[TBL] [Abstract][Full Text] [Related]
11. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo.
Nakagawa Y; Shimizu M; Norose Y; Takahashi M; Takahashi H
Int Immunol; 2013 Jan; 25(1):11-24. PubMed ID: 22945875
[TBL] [Abstract][Full Text] [Related]
12. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
[TBL] [Abstract][Full Text] [Related]
13. Self-veto mechanism of CD8+ cytotoxic effector T cells. Peptide-induced paralysis affects the peptide-MHC-recognizing cytotoxic T lymphocytes and is independent of Fas/Fas ligand interactions.
Bergenthal A; Hofmann M; Heeg K
Eur J Immunol; 1998 Jun; 28(6):1911-22. PubMed ID: 9645373
[TBL] [Abstract][Full Text] [Related]
14. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocytes specific for HIV-1 gp160 antigen and synthetic P18IIIB peptide in an HLA-A11-immunized individual.
Achour A; Lemhammedi S; Picard O; M'Bika JP; Zagury JF; Moukrim Z; Willer A; Beix F; Burny A; Zagury D
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):19-25. PubMed ID: 8179960
[TBL] [Abstract][Full Text] [Related]
16. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
Bergmann C; Stohlmann SA; McMillan M
Eur J Immunol; 1993 Nov; 23(11):2777-81. PubMed ID: 7693478
[TBL] [Abstract][Full Text] [Related]
17. Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide.
Takahashi M; Nakagawa Y; Berzofsky JA; Takahashi H
Int Immunol; 2001 Jan; 13(1):43-51. PubMed ID: 11133833
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes.
Nakagawa Y; Takeshita T; Berzofsky JA; Takahashi H
Immunology; 2000 Sep; 101(1):76-82. PubMed ID: 11012756
[TBL] [Abstract][Full Text] [Related]
19. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
Johnson RP; Trocha A; Buchanan TM; Walker BD
J Exp Med; 1992 Apr; 175(4):961-71. PubMed ID: 1372650
[TBL] [Abstract][Full Text] [Related]
20. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism.
Liu AY; Miskovsky EP; Stanhope PE; Siliciano RF
J Immunol; 1992 Jun; 148(12):3789-98. PubMed ID: 1351088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
